Pulmonx Endobronchial Valve EBV: payments to doctors
Payments that named Pulmonx Endobronchial Valve EBV as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $832K
- Providers
- 1,183
- Transactions
- 2,522
- Average per transaction
- $330
The per-transaction average — $330 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,183 providers the average total is $703, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pulmonx Corporation | $831,881 | 100.0% |